Significance of Micrometastases in the Calculation of the Lymph Node Ratio for Papillary Thyroid Cancer

Overview

Journal Ann Surg Treat Res

Specialty General Surgery

Date 2017 Mar 15

PMID 28289664

Citations 6

Authors

Young Woo Chang

Hwan Soo Kim

Seung Pil Jung

Hoon Yub Kim

Jae Bok Lee

Jeoung Won Bae

Gil Soo Son

Affiliations

Soon will be listed here.

Abstract

Purpose: The lymph node ratio (LNR) is an important prognostic factor in papillary thyroid carcinoma (PTC), but micrometastases in cervical lymph nodes (LNs) are not of great clinical importance. In this study, we analyzed the accuracy of prediction of the prognosis depending on whether micrometastases were included in the number of metastatic LNs when calculating LNR.

Methods: The study included 353 PTC patients who underwent total thyroidectomy with neck LN dissection, and calculated LNR by 2 methods according to whether micrometastases were included in the number of metastatic LNs: Method 1 did not and method 2 did include. To compare the predictive values of LNR by the 2 methods, correlation coefficients and receiver operating characteristic (ROC) curves were analyzed.

Results: Positive correlations were found between LNR and preablation stimulated thyroglobulin (sTg) levels in both methods, but the correlation between method 1 LNR and preablation sTg level was significantly stronger than that for method 2 (Fisher z = 1.7, P = 0.045). The areas under these 2 independent ROC curves were analyzed; the prognostic efficacy of method 1 LNR was more accurate than that of method 2 LNR, and the difference was statistically significant (P = 0.0001).

Conclusion: Regional recurrence of PTC can be predicted more accurately by not including micrometastases in the number of metastatic LNs when calculating LNR.

Citing Articles

Prophylactic Central Compartment Dissection on the Long-Term Outcome of Advanced (N0-T3/T4) Papillary Thyroid Cancer.

Revathy A, Sekhar S, Nair C, R Menon R, Jacob P, J C Babu M Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3256-3260.

PMID: 39130266 PMC: 11306435. DOI: 10.1007/s12070-024-04660-5.

Robotic thyroidectomy using gas-insufflation one-step single-port transaxillary (GOSTA) approach.

Yu D, Chang Y, Ku D, Ko S, Lee H, Son G Surg Endosc. 2023; 37(11):8861-8870.

PMID: 37749201 DOI: 10.1007/s00464-023-10435-w.

Evaluation of Positive Predictors of Micrometastasis in Central Lymph Nodes in Patients with Papillary Thyroid Cancer; A Cross-Sectional Study.

Asherloo H, Nabipoorashrafi S, Kashanizadeh A, Moradi M, Rezaei Tavirani M, Baghai Wadji M Iran J Pathol. 2022; 17(4):442-447.

PMID: 36532637 PMC: 9745751. DOI: 10.30699/IJP.2022.548679.2838.

Oncosuppressor-Mutated Cell-Based Diagnostic Platform for Liquid Biopsy Diagnoses Benign Head and Neck Masses and Predicts Malignancy in Thyroid Nodules: Results from a Consecutive Cohort of Patients.

Abdouh M, Tabah R, Arena V, Arena M, Gao Z, Lorico A Eur Thyroid J. 2021; 10(4):285-294.

PMID: 34395300 PMC: 8314779. DOI: 10.1159/000516421.

Prevalence and predictor for malignancy of contralateral thyroid nodules in patients with unilateral PTMC: a systematic review and meta-analysis.

Wang W, Kong L, Guo H, Chen X Endocr Connect. 2021; 10(6):656-666.

PMID: 34010153 PMC: 8240708. DOI: 10.1530/EC-21-0164.

References

Lee Y, Lim Y, Lee J, Wang S, Kim I, Lee B . Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg. 2010; 34(11):2558-63. DOI: 10.1007/s00268-010-0749-0. View

Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A . Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf). 1985; 23(4):405-11. DOI: 10.1111/j.1365-2265.1985.tb01098.x. View

SAMAAN N, Maheshwari Y, Nader S, HILL Jr C, Schultz P, HAYNIE T . Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab. 1983; 56(6):1131-8. DOI: 10.1210/jcem-56-6-1131. View

Chang Y, Kim H, Kim H, Lee J, Bae J, Son G . Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?. Asian J Surg. 2015; 39(4):197-201. DOI: 10.1016/j.asjsur.2015.02.006. View

Lee Y, Kim S, Kim S, Kim S, Kang H, Lee E . Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg. 2007; 31(10):1954-9. DOI: 10.1007/s00268-007-9171-7. View

Lang B, Wong K, Wan K, Lo C . Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann Surg Oncol. 2011; 19(4):1257-63. PMC: 3309142. DOI: 10.1245/s10434-011-2105-5. View

Schneider D, Chen H, Sippel R . Impact of lymph node ratio on survival in papillary thyroid cancer. Ann Surg Oncol. 2012; 20(6):1906-11. PMC: 3609925. DOI: 10.1245/s10434-012-2802-8. View

Galimberti V, Cole B, Zurrida S, Viale G, Luini A, Veronesi P . Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013; 14(4):297-305. PMC: 3935346. DOI: 10.1016/S1470-2045(13)70035-4. View

Beal S, Chen S, Schneider P, Martinez S . An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg. 2010; 76(1):28-32. View

10.

Teixeira G, Teixeira T, Gubert F, Chikota H, Tufano R . The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery. 2011; 150(6):1161-7. DOI: 10.1016/j.surg.2011.09.019. View

11.

Yip J, Orlov S, Orlov D, Vaisman A, Gomez Hernandez K, Etarsky D . Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence. Head Neck. 2012; 35(4):592-8. DOI: 10.1002/hed.23047. View

12.

Roh J, Park J, Park C . Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg. 2007; 245(4):604-10. PMC: 1877043. DOI: 10.1097/01.sla.0000250451.59685.67. View

13.

Huvos A, HUTTER R, Berg J . Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971; 173(1):44-6. PMC: 1397119. DOI: 10.1097/00000658-197101000-00006. View

14.

Chang Y, Kim H, Jung S, Kim H, Lee J, Bae J . Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio. Int J Clin Oncol. 2016; 21(5):862-868. DOI: 10.1007/s10147-016-0956-2. View

15.

Grant C, Hay I, Gough I, Bergstralh E, Goellner J, McConahey W . Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?. Surgery. 1988; 104(6):954-62. View

16.

Sivanandan R, Soo K . Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001; 88(9):1241-4. DOI: 10.1046/j.0007-1323.2001.01843.x. View

17.

Qubain S, Nakano S, Baba M, Takao S, Aikou T . Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002; 131(3):249-56. DOI: 10.1067/msy.2002.120657. View

18.

DeGroot L, Kaplan E, McCormick M, STRAUS F . Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990; 71(2):414-24. DOI: 10.1210/jcem-71-2-414. View

19.

Ito Y, Fukushima M, Kihara M, Takamura Y, Kobayashi K, Miya A . Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr J. 2012; 59(6):457-64. DOI: 10.1507/endocrj.ej12-0013. View

20.

Lee S, Ho J, Choi J, Kim T, Kim M, Ban E . Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer. Medicine (Baltimore). 2016; 95(5):e2692. PMC: 4748926. DOI: 10.1097/MD.0000000000002692. View